BRPI0612270A2 - compound, pharmaceutical composition, and use of a compound - Google Patents

compound, pharmaceutical composition, and use of a compound

Info

Publication number
BRPI0612270A2
BRPI0612270A2 BRPI0612270A BRPI0612270A BRPI0612270A2 BR PI0612270 A2 BRPI0612270 A2 BR PI0612270A2 BR PI0612270 A BRPI0612270 A BR PI0612270A BR PI0612270 A BRPI0612270 A BR PI0612270A BR PI0612270 A2 BRPI0612270 A2 BR PI0612270A2
Authority
BR
Brazil
Prior art keywords
compound
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
BRPI0612270A
Other languages
Portuguese (pt)
Inventor
Emily Reinhard
Hermogenes Jimenez
Mathivanan Packiarajan
Vrej Jubian
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of BRPI0612270A2 publication Critical patent/BRPI0612270A2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0612270A 2005-06-23 2006-06-21 compound, pharmaceutical composition, and use of a compound BRPI0612270A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15979405A 2005-06-23 2005-06-23
PCT/US2006/024043 WO2007002126A1 (en) 2005-06-23 2006-06-21 Alkyl sulfonamide derivatives

Publications (1)

Publication Number Publication Date
BRPI0612270A2 true BRPI0612270A2 (en) 2016-09-06

Family

ID=37595447

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0612270A BRPI0612270A2 (en) 2005-06-23 2006-06-21 compound, pharmaceutical composition, and use of a compound

Country Status (13)

Country Link
JP (1) JP2008546787A (en)
KR (1) KR20080018206A (en)
CN (1) CN101203499A (en)
AR (1) AR054480A1 (en)
AU (1) AU2006262319A1 (en)
BR (1) BRPI0612270A2 (en)
CA (1) CA2613377A1 (en)
EA (1) EA200800111A1 (en)
IL (1) IL187894A0 (en)
MX (1) MX2007015998A (en)
NO (1) NO20080411L (en)
TW (1) TW200736237A (en)
WO (1) WO2007002126A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ572381A (en) 2006-04-28 2011-01-28 Shionogi & Co Amine derivative having npy y5 receptor antagonist activity
SA08290668B1 (en) 2007-10-25 2012-02-12 شيونوجي آند كو.، ليمتد Amine Derivatives having NPY Y5 receptor antagonistic activity and the uses thereof
US8227618B2 (en) 2009-04-23 2012-07-24 Shionogi & Co., Ltd. Amine-derivatives having NPY Y5 receptor antagonistic activity and the uses thereof
MX358421B (en) * 2011-04-27 2018-08-20 Shionogi & Co 5-membered ring aromatic heterocyclic derivative having npy y5 receptor antagonistic activity.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6989379B1 (en) * 1999-04-22 2006-01-24 H. Lundbick A/S Selective NPY (Y5) antagonists

Also Published As

Publication number Publication date
EA200800111A1 (en) 2008-06-30
MX2007015998A (en) 2008-03-07
KR20080018206A (en) 2008-02-27
NO20080411L (en) 2008-01-22
JP2008546787A (en) 2008-12-25
CA2613377A1 (en) 2007-01-04
AU2006262319A1 (en) 2007-01-04
WO2007002126A1 (en) 2007-01-04
CN101203499A (en) 2008-06-18
IL187894A0 (en) 2008-03-20
WO2007002126A8 (en) 2007-03-01
TW200736237A (en) 2007-10-01
AR054480A1 (en) 2007-06-27

Similar Documents

Publication Publication Date Title
BRPI0609802A2 (en) compound, pharmaceutical composition and use of a compound
BRPI0614730A2 (en) compound, pharmaceutical composition, and use of a compound
BRPI0716171A2 (en) compound, pharmaceutical composition and use of a compound.
BRPI0614205A2 (en) compound, pharmaceutical composition and compound use
BRPI0618904A2 (en) compound, pharmaceutical composition, and compound use
BRPI0810696A2 (en) COMPOUND, PHARMACEUTICAL COMPOSITION, AND, USE OF A COMPOUND
BRPI0815709A2 (en) composition, pharmaceutical composition, and use of a compound.
BRPI0810161A2 (en) COMPOUND, PHARMACEUTICAL PREPARATION, PHARMACEUTICAL COMPOSITION, AND USE OF A COMPOUND
BRPI0614162A2 (en) dermocosmetic and use of a compound
BRPI0919942A2 (en) COMPOUND, PHARMACEUTICAL COMPOSITION, AND, USE OF A COMPOUND
BRPI0907562A2 (en) compound, pharmaceutical composition, and use of a compound
BRPI0921375A2 (en) compound, pharmaceutical composition, and use of a compound
BRPI0716698A2 (en) COMPOUND, PHARMACEUTICAL COMPOSITION AND USE OF A COMPOUND
BRPI0810019A2 (en) COMPOUND, PHARMACEUTICAL COMPOSITION, AND, USE OF A COMPOUND
BRPI0611025A2 (en) compound, use of a compound, and pharmaceutically acceptable composition
BRPI0819696A2 (en) Compounds of 2-phenylpyrimidine derivatives, pharmaceutical composition and use of a compound
BRPI0821115A2 (en) Aminotriazole-derived compound, drug, pharmaceutical composition and use of compound
BRPI0812942A2 (en) COMPOUND, PHARMACEUTICAL COMPOSITION AND USE OF A COMPOUND
BRPI0921879A2 (en) compound, pharmaceutical composition, and use of a compound
BRPI0809977A2 (en) USE OF A COMPOUND, COMPOUNDS AND PHARMACEUTICAL COMPOSITION CONTAINING
RU2398586C3 (en) PHARMACEUTICAL COMPOSITION
BRPI0917579A2 (en) compound, pharmaceutical composition, methods, and use of a compound
BRPI0717699A2 (en) "COMPOSITION AND ITS PROCESSES FOR PREPARATION, USE OF A COMPOSITION, AND COMESTIC USE OF A COMPOSITION!
BRPI0906937A2 (en) compound, pharmaceutical composition, and use of a compound
BRPI0611748A2 (en) compound, pharmaceutical composition, and use of a pharmaceutical composition

Legal Events

Date Code Title Description
B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]

Free format text: SOLICITA-SE A REGULARIZACAO DA PROCURACAO, UMA VEZ QUE BASEADO NO ARTIGO 216 PAR 1O DA LPI, O DOCUMENTO DE PROCURACAO DEVE SER APRESENTADO NO ORIGINAL, TRASLADO OU FOTOCOPIA AUTENTICADA.

B11Z Dismissal: petition dismissal - article 216, par 2 of industrial property law

Free format text: REFERENTE A PETICAO NO 20070181894/RJ DE 20/12/2007.

B06H Technical and formal requirements: requirement cancelled [chapter 6.8 patent gazette]

Free format text: O DESPACHO 6.7 ESTA SENDO ANULADO TENDO POR BASE A DETERMINACAO DO DIRETOR DE PATENTES, A QUAL E CALCADA NO PARECER NO 0003-2014 AGU/PGF/PFE/INPI/COOPHI-LBC-1.0.

B11M Decision cancelled [chapter 11.13 patent gazette]

Free format text: O DESPACHO 11.6.1 ESTA SENDO ANULADO TENDO POR BASE A DETERMINACAO DO DIRETOR DE PATENTES, A QUAL E CALCADA NO PARECER NO 0003-2014 AGU/PGF/PFE/INPI/COOPHI-LBC-1.0.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]